Aimmune Therapeutics Inc (AIMT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2020-10-15 | 2020-10-13 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
10,681,704
+83.9%
34.50USD 368,518,788 |
10,681,704 +83.9% | 34.50 | USD 368,518,788 | |
| 2020-10-15 | 2020-10-13 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
43,435,583
+inf%
34.50USD 1,498,527,614 |
43,435,583 +inf% | 34.50 | USD 1,498,527,614 | |
| 2020-03-19 | 2020-03-18 | B Purchase | Non-Executive Director |
16,213
+29.8%
11.06USD 179,345 |
16,213 +29.8% | 11.06 | USD 179,345 | |
| 2020-03-19 | 2020-03-17 | B Purchase | Non-Executive Director |
8,787
+19.3%
11.50USD 101,051 |
8,787 +19.3% | 11.50 | USD 101,051 | |
| 2020-03-19 | 2020-03-17 | B Purchase | Non-Executive Director |
100,000
+1.7%
11.40USD 1,139,650 |
100,000 +1.7% | 11.40 | USD 1,139,650 | |
| 2020-03-17 | 2020-03-13 | B Purchase |
Chief Commercial Officer Officer |
3,000
+13.6%
14.76USD 44,266 |
3,000 +13.6% | 14.76 | USD 44,266 | |
| 2020-03-12 | 2020-03-12 | B Purchase |
Chief Financial Officer Officer |
1,000
+2.4%
15.10USD 15,100 |
1,000 +2.4% | 15.10 | USD 15,100 | |
| 2020-03-10 | 2020-03-10 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
2,665
+2.2%
18.74USD 49,934 |
2,665 +2.2% | 18.74 | USD 49,934 | |
| 2020-03-10 | 2020-03-09 | B Purchase |
Chief Financial Officer Officer |
1,000
+2.4%
18.97USD 18,970 |
1,000 +2.4% | 18.97 | USD 18,970 | |
| 2020-04-24 | 2020-02-07 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
525,634
+inf%
319.68USD 168,032,049 |
525,634 +inf% | 319.68 | USD 168,032,049 | |
| 2020-04-24 | 2020-02-07 | B Purchase |
Societe des Produits Nestle S.A. Large shareholder |
1,000,000
+8.5%
31.97USD 31,970,000 |
1,000,000 +8.5% | 31.97 | USD 31,970,000 | |
| 2020-01-21 | 2020-01-16 | PS Planned sale |
See Remarks |
400
-0.9%
37.00USD 14,800 |
400 -0.9% | 37.00 | USD 14,800 | |
| 2020-01-03 | 2020-01-02 | PS Planned sale |
Chief Medical Officer |
20,000
-48.5%
35.00USD 700,038 |
20,000 -48.5% | 35.00 | USD 700,038 | |
| 2019-12-30 | 2019-12-26 | PS Planned sale |
Sheehy Douglas T. See Remarks Officer |
10,000
-18.0%
33.03USD 330,322 |
10,000 -18.0% | 33.03 | USD 330,322 | |
| 2019-12-11 | 2019-12-09 | PS Planned sale |
ADELMAN DANIEL C MD Chief Medical Officer Officer |
20,000
-48.5%
30.04USD 600,716 |
20,000 -48.5% | 30.04 | USD 600,716 | |
| 2019-09-20 | 2019-09-18 | B Purchase |
Chief Financial Officer |
1,550
+4.8%
22.57USD 34,977 |
1,550 +4.8% | 22.57 | USD 34,977 | |
| 2020-04-24 | 2018-11-28 | B Purchase |
Nestle Health Science US Holdings, Inc. Large shareholder |
3,237,529
+38.1%
30.27USD 98,000,003 |
3,237,529 +38.1% | 30.27 | USD 98,000,003 | |
| 2018-11-21 | 2018-11-19 | S Sale |
Barrowcliffe Susan E. General Manager, Europe Officer |
40,000
-81.0%
30.04USD 1,201,600 |
40,000 -81.0% | 30.04 | USD 1,201,600 | |
| 2018-11-19 | 2018-11-19 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
50
+0.1%
27.56USD 1,378 |
50 +0.1% | 27.56 | USD 1,378 | |
| 2018-11-19 | 2018-11-19 | B Purchase |
Dallas Jayson Donald Alexander President and CEO Executive Director |
3,600
+6.0%
27.56USD 99,209 |
3,600 +6.0% | 27.56 | USD 99,209 |